Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Long Road Home
lungcanc
2017 ASCO Annual Meeting
5th AACR-IASLC International Joint Conference: Translational Progress through Basic Research
IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
IASLC SCLC Meeting Program, Faculty to Reflect the Field’s Pivotal, Recent...
lungcanc
IASLC Small Cell Lung Cancer Workshop
lungcanc
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
lungcanc
Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru
lungcanc
IASLC’s Inaugural Mesothelioma Meeting Sets Baseline for Strategic Approach to Patient...
lungcanc
Top Science in Lung Cancer Featured at WCLC 2018
lungcanc
IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology
lungcanc
IASLC Workshop in Lung Cancer Clinical Research
lungcanc
Lung Cancer 360 Forum Overview: C.A.I.R.O Journal Club’s Fourth Anniversary
lungcanc
2017 ASCO Annual Meeting
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS